Professor Avni Sali AM announces his appointment to the Australian Advisory Council on the medicinal use of cannabis

Date: 24-11-2021

Founder of the National Institute of Integrative Medicine (NIIM), Professor Avni Sali AM has been appointed to the Australian Advisory Council on the Medical Use of Cannabis, providing an important opportunity for an ‘Integrative Medicine’ voice to be part of a national government committee. 

Through his advisory role, Professor Sali AM will be able to contribute to this developing field of medicine ensuring access to Medical Cannabis (MC) is as widely and readily available in Australia as other countries. 

Professor Sali AM says, “I have a professional interest in supporting the education of the public about the validity of Medical Cannabis in the treatment of chronic illness, and insupporting the education of doctors to become authorised prescribers.” His appointment provides valuable  recognition by the Federal Government of the value of an Integrative Medicine perspective. 

In late 2019, more than 18,000 patients in Australia had accessed medicinal cannabis, prescribed by more than 1465 medical practitioners, mostly GPs. The number of approvals is rapidly increasing with a total of more than 28,000 individual applications approved as of 31 December 2019.1 Currently, The NIIM Ethics Committee, the only integrative medicine academic institute that has such a committee, processes approximately 100 applications monthly from medical practitioners to be registered prescribers of Medicinal Cannabis. 

“The Advisory Committee will help with advocacy for much needed research funding in this field, and in lowering the costs of Medical Cannabis for consumers. More than 100 different Medicinal Cannabis products are accessible through the TGA Authorised Prescriber Scheme,” says Professor Sali AM, who prescribes Medical Cannabis for his patients. “People presenting with chronic health conditions are often seeking other options, when conventional medicine cannot fully address their issues.” Medicinal Cannabis is being used to treat conditions such as anxiety, PTSD, pain, Multiple Sclerosis, Parkinson’s, Epilepsy, cancer-induced nausea and vomiting, cancer, Palliative care and insomnia. 

Professor Sali AM has been appointed to this role until 30 June 2023. The Advisory Council forms part of the Medicinal Cannabis Section, Office of Drug Control, Australian Government Department of Health. 

For further information contact:  Media Contact, National Institute of Integrative Medicine | Email: 


  1. Medicinalcannabis